Manual resuscitator recalled due to incorrect B/V filter assembly that could delay therapy. May cause hypoxia, hypercapnia, or death if used.
Similar Posts
Pediatrics and Maternal Health
DPMH oversees quality initiatives which promote and necessitate the study of drug and biological products in the pediatric population and to improve pregnancy and lactation-related information in product labeling.Recently Issued Guidance Documents
This page lists Recently Issued CBER and Cross-Center Guidance Documents.Promotional Labeling and Advertising Considerations for Prescription Biological Reference Products, Biosimilar Products, and Interchangeable Biosimilar Products: Questions and Answers
The guidance addresses questions that manufacturers, packers, distributors, and their representatives (firms) may have when developing FDA-regulated promotional labeling and advertisements for prescription reference products, biosimilar products, and interchangeable biosimilar products.Drug Safety Oversight Board
The DSB is composed of representatives from two FDA Centers and eight other federal government agencies, the Agency for Healthcare Research and Quality, Centers for Disease Control and Prevention, Centers for Medicare and Medicaid Services, Department of Defense.Symptomatic Nonerosive Gastroesophageal Reflux Disease: Developing Drugs for Treatment
Symptomatic Nonerosive Gastroesophageal Reflux Disease: Developing Drugs for TreatmentKath Khemicals LLC – 711699 – 09/22/2025
CGMP/Finished Pharmaceuticals/Adulterated
